Very Early endoscopy may arrest acute upper GI bleeding, cut mortality: BMC

Written By :  Jacinthlyn Sylvia
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-12-20 15:00 GMT   |   Update On 2024-12-20 15:01 GMT

A new study published in the journal of BMC Gastroenterology showed that the 30-day mortality rate for older individuals with acute non-variceal upper gastrointestinal hemorrhage was considerably decreased by very early endoscopy (<12 hours). There is still considerable debate over the best time to do an endoscopy for acute upper gastrointestinal bleeding (UGIB). Differences in the current guidelines for the time between presentation and endoscopy reflect this.

For the majority of UGIB patients, endoscopy within 24 hours is typically considered suitable. But organizing this is still difficult, especially in smaller centers on the weekends. Studies conducted in recent years have detailed the precise early identification of individuals with a very low chance of a bad outcome following UGIB, allowing for early outpatient endoscopic arrangements and the avoidance of inpatient. Thus, Yavuz Cagir and colleagues carried out this study to assess the ideal endoscopic duration in elderly patients with nonvariceal upper gastrointestinal bleeding (NVUGIB).

Based on endoscopic timing, the patients over 65 who present with NVUGIB fall into one of three groups as very early endoscopy (< 12 h), early endoscopy (12-24 h), or late endoscopy (> 24 h). For patients with unstable hemodynamic settings, continuous bleeding, or a low hematocrit despite transfusion, endoscopic intervention was performed during the first 12 hours. The clinical outcomes under investigation were; 30-day mortality was the primary objective, whereas duration of hospital stay, rebleeding, and the necessity for endoscopic intervention were regarded as secondary goals.

Of the 468 people in the research, 260 were over 65. 180 (69.2%) patients over 65 and 150 (72.1%) younger patients had extremely early endoscopies (within 12 hours) based on the endoscopic schedule (p > 0.05). The patients over 65 and younger patients had early endoscopies (12–24 hours) in 53 (20.4%) and 41 (19.7%) cases, respectively, whereas 27 (10.4%) and 17 (8.2%) patients had late endoscopies (24–48 hours). The clinical outcomes of comparisons between groups and subgroups depending on endoscopy time in the population aged 65 and above.

When groups were compared, it was discovered that the very early endoscopy group had a significantly lower risk of requiring surgical/radiological intervention than the late endoscopy group, and 30-day mortality rates by endoscopy timing were statistically quite distinct in the early endoscopy group (7.5%), very early group (15.6%), and late endoscopy group (29.6%).

Endoscopy within 24 to 48 hours (late) was a separate predictor of rebleeding throughout the hospital stay. Overall, early endoscopy may help control acute UGIB, particularly in the elderly with significant comorbidities and severe bleeding.

Source:

Cagir, Y., Durak, M. B., & Yuksel, I. (2024). Optimal endoscopy timing in elderly patients presenting with acute non-variceal upper gastrointestinal bleeding. In BMC Gastroenterology (Vol. 24, Issue 1). Springer Science and Business Media LLC. https://doi.org/10.1186/s12876-024-03541-z

Tags:    
Article Source : BMC Gastroenterology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News